cnbc's meg tirrell explains regeneron's antibody cocktail
Published 3 years ago • 9.5K plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
2:21
cnbc's meg tirrell explains how the coronavirus vaccine data monitoring process works
-
4:29
why regeneron's antibody drug will be in short supply
-
1:29
regeneron ceo: antibody cocktail offered to biden's team
-
4:00
here's how drug rebates work
-
2:21
regeneron antibody cocktail works against u.k. and south african variants: study
-
6:04
market insight: 'equilibrium rate' could be closer than investors think | reuters
-
4:27
countdown to nvidia earnings: here's what investors can expect
-
6:58
president donald trump using regeneron cocktail was a wholly appropriate call: dr. scott gottlieb
-
4:17
regeneron reports antibody drug lowers risk of medical visits by 57%
-
3:11
regeneron chief scientist explains promising results for covid-19 antibody cocktail
-
4:45
regeneron ceo on teaming up with roche to develop covid-19 antibody cocktail
-
1:22
regeneron reports positive results on initial data for covid-19 antibody drug
-
2:32
regeneron covid-19 'antibody cocktail' drug enters late-stage trials
-
2:01
regeneron's antibody drug reduces risk of death in some covid patients
-
2:40
coronavirus: developing a therapy for preventing and fighting the outbreak, regeneron says
-
1:08
regeneron receives $450 million federal contract for covid-19 antibody drug
-
5:32
regeneron's science chief on starting clinical trials for covid-19 antibody drug
-
3:03
intellia, regeneron complete first systemic delivery of crispr in body
-
2:55
regeneron ceo on distribution of covid-19 antibody cocktail
-
1:26
regeneron to ask fda to expand eua for antibody treatment after positive study results
-
1:13
what to watch at the world's largest cancer conference
-
1:20
coronavirus update: fda gives emergency authorization to test with faster results